Company profile
Stoke Therapeutics, Inc. Insider Trading
STOKEvery SEC Form 4 insider trading filing for Stoke Therapeutics, Inc. (STOK) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001623526
- Filings
- 163
- Insiders
- 21
- Last filing
- 2026-08-18
Activity summary
Mixed insider activity over the last 30 days: 6 purchases and 6 sales (12 transactions total).
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Stoke Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $44.5M.
90 day insight
Over the last 90 days, Stoke Therapeutics, Inc. insiders bought $0 (14 transactions) and sold $647K (6 transactions).
- Most active insider: Harrison Seth Loring with 17 transactions totaling $0.
- Largest single sale: $382K by Kaye Edward M. MD on Aug 18, 2026.
- 50% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Kaye Edward M. MD | STOK | Sale | 11,930 | $32.01 | $382K |
| Aug 18, 2026 | Ticho Barry | STOK | Sale | 4,525 | $32.01 | $145K |
| Aug 18, 2026 | Ticho Barry | STOK | Sale | 242 | $32.47 | $8K |
| Aug 18, 2026 | Allan Jonathan | STOK | Sale | 145 | $32.47 | $5K |
| Aug 18, 2026 | Kaye Edward M. MD | STOK | Sale | 637 | $32.47 | $21K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=STOK" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Stoke Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →